Literature DB >> 27842990

Review of sentinel node procedure in cN0 head and neck squamous cell carcinomas. Guidelines from the French evaluation cooperative subgroup of GETTEC.

R Garrel1, G Poissonnet2, S Temam3, G Dolivet4, N Fakhry5, D de Raucourt6.   

Abstract

The reliability of the sentinel lymph node (SN) technique has been established for more than ten years in T1-T2 oral cavity and oropharynx squamous cell carcinoma. Although most authors stress the necessity of rigorous implementation, there are no agreed guidelines. Moreover, other indications have been described, in other anatomical areas of the upper aerodigestive tract and in case of previous surgery or radiotherapy. SN expert teams, under the GETTEC head and neck tumor study group, conducted a review of the key points for implementation in head and neck cancers through guidelines and a review of classical and extended indications. Reliability depends on respecting key points of preoperative landmarking by lymphoscintigraphy, and intraoperative SN sampling and histological analysis. The SN technique is the best means of diagnosing occult lymph node involvement, whatever the primary tumor location, T stage or patient history.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; GETTEC; Head and neck squamous cell carcinoma; Lymphoscintigraphy; Micrometastasis; N0; Sentinel node

Mesh:

Year:  2016        PMID: 27842990     DOI: 10.1016/j.anorl.2016.10.004

Source DB:  PubMed          Journal:  Eur Ann Otorhinolaryngol Head Neck Dis        ISSN: 1879-7296            Impact factor:   2.080


  2 in total

1.  Sentinel Lymph Node Biopsy Versus Elective Neck Dissection: Long-Term Oncologic Outcomes in Clinically Node-Negative Tongue Cancer.

Authors:  Woori Park; Hokyung Jin; Yujin Heo; Han-Sin Jeong; Young-Ik Son; Man Ki Chung; Chung-Hwan Baek
Journal:  Clin Exp Otorhinolaryngol       Date:  2021-03-30       Impact factor: 3.372

2.  Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.

Authors:  Giri Krishnan; Nynke S van den Berg; Naoki Nishio; Georgina Juniper; Jaqueline Pei; Quan Zhou; Guolan Lu; Yu-Jin Lee; Kimberly Ramos; Andrei H Iagaru; Fred M Baik; Alexander D Colevas; Brock A Martin; Eben L Rosenthal
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.